NANS members automatically belong to the multidisciplinary International Neuromodulation Society (INS). INS member benefits for clinicians, researchers, and engineers are described on this page.
Founded in 1989, the INS has grown to 16 chapters around the world, and by 2014 had four more chapters in formation. Among their regional activities, each chapter offers an annual scientific meeting. In 1995, NANS became the first chapter of the INS, and remains its largest.
Since 1998 the official journal of the INS has been the MEDLINE-indexed, peer-reviewed journal Neuromodulation: Technology at the Neural Interface, which all NANS members receive as part of their membership. In a recent new benefit, the journal publisher, Wiley, now offers discount opportunities that members can access by logging into the INS or NANS website and navigating to the area for reading the journal online.
In addition, NANS members receive a reduced rate for the biennial INS World Congress. The two-day preconference (including an innovations summit) and three-day main scientific program includes plenary lectures, sessions by world-renowned faculty concerning the full range of neuromodulation topics, poster presentations, and the opportunity to receive CME credit.
As part of their membership in INS, members of NANS:
To see a screenshot of the INS Members Only menu, please click here.
In addition, INS also has an extensive online library of noncommercial patient education content and handouts – material that received a trust code seal in 2013 from the external certifying organization Health On the Net – at www.neuromodulation.com/for-patients. This exclusive content vetted by INS specialists includes a lay-level glossary of common neuromodulation terms and descriptions of common conditions and treatments, convenient for sharing either through links or hard-copy prints.
INS website visitors can stay up-to-date with breaking news in the industry– including research news – through the INS homepage’s rolling news briefs (also available as an RSS feed).
INS also lists clinical trials in neuromodulation that are registered on clinicaltrials.gov and the ISRCTN Register.
Finally, members receive a quarterly e-newsletter that often includes an article addressing clinical advances or issues such as regional device registries. Archived newsletters, news releases, and news briefs are available in the INS newsroom, http://www.neuromodulation.com/newsroom.
Through its Executive Office and member volunteers, INS also proactively interacts with external information partners, news organizations and social media to expand awareness and understanding of neuromodulation therapies.
The mission of the North American Neuromodulation Society (NANS) Foundation is to support multidisciplinary collaboration among patients, clinicians, scientists, engineers, and others to advance neuromodulation through research and education.
American Academy of Neurology
Advancing Neurology. Advancing you.
Date: April 22-28, 2017
Location: Boston, Massachusetts
International Neuromodulation Society 13th World Congress
Date: May 27, 2017 - June 1, 2017
Location: Edinburgh, Scotland